Kinga Kamińska, dr

Kinga Kamińska, dr

+48 12 6623258
room 126

Achievements

  • Publications

Depressive-like neurochemical and behavioral markers of Parkinson's disease after 6-OHDA administered unilaterally to the rat medial forebrain bundle

Autorzy: Kamińska, K., Lenda, T., Konieczny, J., Czarnecka, A., Lorenc-Koci, E.

DOI: 10.1016/j.pharep.2017.05.016
Date: 2017-01-01

The significance of rotational behavior and sensitivity of striatal dopamine receptors in hemiparkinsonian rats: A comparative study of lactacystin and 6-OHDA

Autorzy: Konieczny, J., Czarnecka, A., Lenda, T., Kamińska, K., Antkiewicz-Michaluk, L.

DOI: 10.1016/j.neuroscience.2016.10.070
Date: 2017-01-01

Decreased behavioral response to intranigrally administered GABA<inf>A</inf> agonist muscimol in the lactacystin model of Parkinson's disease may result from partial lesion of nigral non-dopamine neurons: Comparison to the classical neurotoxin 6-OHDA

Autorzy: Konieczny, J., Czarnecka, A., Kamińska, K., Lenda, T., Nowak, P.

DOI: 10.1016/j.bbr.2015.01.043
Date: 2015-01-01

Chronic l-DOPA treatment attenuates behavioral and biochemical deficits induced by unilateral lactacystin administration into the rat substantia nigra

Autorzy: Konieczny, J., Czarnecka, A., Lenda, T., Kamińska, K., Lorenc-Koci, E.

DOI: 10.1016/j.bbr.2013.12.019
Date: 2014-01-01

Molsidomine, a nitric oxide donor, modulates rotational behavior and monoamine metabolism in 6-OHDA lesioned rats treated chronically with L-DOPA

Autorzy: Lorenc-Koci, E., Czarnecka, A., Lenda, T., Kamińska, K., Konieczny, J.

DOI: 10.1016/j.neuint.2013.09.021
Date: 2013-01-01

See also